Stay updated on Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial

Sign up to get notified when there's something new on the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A new page revision entry 'Revision: v3.3.3' was added; the items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.
    Difference
    0.0%
    Check dated 2025-12-23T12:43:19.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The history now shows updates to Contacts/Locations and Study Status (version 406) with entries dated 2025-11-15 and 2025-12-05.
    Difference
    0.1%
    Check dated 2025-12-08T23:30:53.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The 2025-11-17 version adds Contacts/Locations and Study Status sections and records Revision: v3.3.2, while 2025-09-22 notes the deletion of Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T16:59:16.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The notice about lapse in government funding and operating status at the top of the page was removed.
    Difference
    0.1%
    Check dated 2025-11-17T15:03:36.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The Record History shows a long sequence of versions from 2018 to 2025, with updates to Study Status and Contacts/Locations along with other sections.
    Difference
    0.0%
    Check dated 2025-11-03T01:30:07.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    - Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-05T10:29:56.000Z thumbnail image

Stay in the know with updates to Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page.